Copy of US HB9077 text not on file, redirecting to the bill draft list.
Bill Title: To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Sponsorship: Partisan Bill (Democrat 1)
Status: (Introduced) 2026-05-29 - Referred to the House Committee on Energy and Commerce.
[HB9077 Detail]
Bill Drafts
| Revision | Date | Format | Source | View |
|---|
| No bill text drafts for US Congress HB9077 currently on file. |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|
| No bill amendments currently on file for US Congress HB9077 |
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|
| No supplemental documents for US Congress HB9077 currently on file. |
